查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2138208

全球生物標記市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Biomarkers Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球生物標記市場預計將從2025年的634.4億美元成長至2034年的1,581.2億美元，2026年至2034年的複合年成長率（CAGR）為10.68%。精準醫療和疾病早期檢測需求的不斷成長推動了全球生物標記市場的強勁成長。生物標記廣泛應用於診斷、藥物研發和臨床研究，用於評估疾病進展和治療效果。癌症和心血管疾病等慢性病盛行率的上升進一步促進了市場擴張。

基因組學、蛋白質組學和分子診斷技術的進步是關鍵的成長要素。製藥公司正在擴大生物標記在臨床試驗中的應用，以提高藥物的療效和安全性。此外，研發投入的增加以及生技公司與學術機構之間的合作，正在加速創新。

未來，人工智慧（AI）和巨量資料分析的整合有望推動該市場的發展。對個人化醫療日益成長的關注將進一步刺激對生物標記檢測的需求。開發中國家醫療基礎設施的不斷改善也將創造新的機會。隨著診斷技術的持續發展，生物標記市場預計將保持長期成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的關鍵促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場趨勢進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球生物標記市場：按類型分類

  • 市場分析、洞察與預測
  • 安全生物標記
  • 療效生物標記
  • 預測性生物標記
  • 替代生物標記
  • 動態物標誌物
  • 預後生物標記
  • 檢驗生物標記

第5章 全球生物標記市場：依產品分類

  • 市場分析、洞察與預測
  • 消耗品
  • 服務
  • 軟體

第6章 全球生物標記市場：依應用分類

  • 市場分析、洞察與預測
  • 診斷
  • 藥物發現與開發
  • 個人化醫療
  • 疾病風險評估
  • 其他

第7章 全球生物標記市場：依疾病分類

  • 市場分析、洞察與預測
  • 癌症
  • 心血管疾病
  • 神經系統疾病
  • 免疫疾病
  • 其他

第8章 全球生物標記市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Epigenomics AG
    • GE HealthCare Technologies Inc
    • Johnson & Johnson Services Inc
    • Thermo Fisher Scientific Inc
    • Bio-Rad Laboratories Inc
    • Siemens Healthineers AG
    • QIAGEN NV
    • Merck KGaA
    • PerkinElmer Inc
    • Agilent Technologies Inc
    • Eurofins Scientific SE
簡介目錄
Product Code: VMR112113891

The global biomarkers market size is expected to reach USD 158.12 Billion in 2034 from USD 63.44 Billion in 2025, growing at a CAGR of 10.68% during 2026-2034.The Global Biomarkers Market is experiencing strong growth due to rising demand for precision medicine and early disease detection. Biomarkers are widely used in diagnostics, drug development, and clinical research to assess disease progression and treatment response. Increasing prevalence of chronic diseases such as cancer and cardiovascular disorders is fueling market expansion.

Key growth drivers include advancements in genomics, proteomics, and molecular diagnostics technologies. Pharmaceutical companies are increasingly utilizing biomarkers in clinical trials to improve drug efficacy and safety. Additionally, growing investments in research and development and collaborations between biotech firms and academic institutions are accelerating innovation.

Looking ahead, the market is expected to benefit from integration with artificial intelligence and big data analytics. Personalized medicine initiatives will further increase demand for biomarker-based testing. Expanding healthcare infrastructure in developing economies will create new opportunities. As diagnostic technologies continue to evolve, the biomarkers market is poised for long-term growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Predictive Biomarkers
  • Surrogate Biomarkers
  • Pharmacodynamic Biomarkers
  • Prognostics Biomarkers
  • Validation Biomarkers

By Product

  • Consumable
  • Services
  • Software

By Application

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Disease Risk Assessment
  • Others

By Disease

  • Cancer
  • Cardiovascular Diseases
  • Neurological Diseases
  • Immunological Diseases
  • Others

COMPANIES PROFILED

  • F. Hoffmann-La Roche Ltd, Abbott Laboratories, Epigenomics AG, GE HealthCare Technologies Inc., Johnson & Johnson Services Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Siemens Healthineers AG, QIAGEN N.V., Merck KGaA, PerkinElmer Inc., Agilent Technologies Inc., Eurofins Scientific SE

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOMARKERS MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Safety Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Efficacy Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Predictive Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Surrogate Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Pharmacodynamic Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Prognostics Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Validation Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOMARKERS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Consumable Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOMARKERS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Disease Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOMARKERS MARKET: BY DISEASE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Disease
  • 7.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Neurological Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Immunological Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOMARKERS MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Type
    • 8.2.2 By Product
    • 8.2.3 By Application
    • 8.2.4 By Disease
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Type
    • 8.3.2 By Product
    • 8.3.3 By Application
    • 8.3.4 By Disease
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Spain
    • 8.3.10 Russia
    • 8.3.11 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Type
    • 8.4.2 By Product
    • 8.4.3 By Application
    • 8.4.4 By Disease
    • 8.4.5 China
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 India
    • 8.4.9 Australia
    • 8.4.10 South East Asia
    • 8.4.11 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Type
    • 8.5.2 By Product
    • 8.5.3 By Application
    • 8.5.4 By Disease
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Type
    • 8.6.2 By Product
    • 8.6.3 By Application
    • 8.6.4 By Disease
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOMARKERS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 F. Hoffmann-La Roche Ltd
    • 10.2.2 Abbott Laboratories
    • 10.2.3 Epigenomics AG
    • 10.2.4 GE HealthCare Technologies Inc
    • 10.2.5 Johnson & Johnson Services Inc
    • 10.2.6 Thermo Fisher Scientific Inc
    • 10.2.7 Bio-Rad Laboratories Inc
    • 10.2.8 Siemens Healthineers AG
    • 10.2.9 QIAGEN N.V
    • 10.2.10 Merck KGaA
    • 10.2.11 PerkinElmer Inc
    • 10.2.12 Agilent Technologies Inc
    • 10.2.13 Eurofins Scientific SE